{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:50:21Z","timestamp":1792090221820,"version":"4.4.0"},"reference-count":34,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,9,15]]},"DOI":"10.2967\/jnumed.126.272939","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:10:15Z","timestamp":1792087815000},"page":"jnumed.126.272939","source":"Crossref","is-referenced-by-count":0,"title":["B7H3-Targeted Molecular Imaging for Highly Specific Diagnosis and In\u00a0Vivo Noninvasive Detection of B7H3 in Breast Cancer"],"prefix":"10.2967","author":[{"given":"Lei","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2026101511101072000_jnumed.126.272939v1.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026101511101072000_jnumed.126.272939v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016"},{"key":"2026101511101072000_jnumed.126.272939v1.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.388"},{"key":"2026101511101072000_jnumed.126.272939v1.4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","article-title":"Radiomics in breast cancer classification and prediction","volume":"72","author":"Conti","year":"2021","journal-title":"Semin Cancer Biol."},{"key":"2026101511101072000_jnumed.126.272939v1.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.157859"},{"key":"2026101511101072000_jnumed.126.272939v1.6","doi-asserted-by":"crossref","first-page":"e232209","DOI":"10.1148\/radiol.232209","article-title":"Comparison of an Affibody-based molecular probe and 18F-FDG for detecting HER2-positive breast cancer at PET\/CT","volume":"311","author":"Guo","year":"2024","journal-title":"Radiology."},{"key":"2026101511101072000_jnumed.126.272939v1.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266254"},{"key":"2026101511101072000_jnumed.126.272939v1.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157368"},{"key":"2026101511101072000_jnumed.126.272939v1.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268564"},{"key":"2026101511101072000_jnumed.126.272939v1.10","doi-asserted-by":"crossref","first-page":"e185408","DOI":"10.1172\/JCI185408","article-title":"68Ga-MY6349 PET\/CT imaging to assess Trop2 expression in multiple types of cancer","volume":"135","author":"Chen","year":"2024","journal-title":"J Clin Invest."},{"key":"2026101511101072000_jnumed.126.272939v1.11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010924"},{"key":"2026101511101072000_jnumed.126.272939v1.12","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01364-7"},{"key":"2026101511101072000_jnumed.126.272939v1.13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","article-title":"New frontiers in immune checkpoint B7-H3 (CD276) research and drug development","volume":"22","author":"Getu","year":"2023","journal-title":"Mol Cancer."},{"key":"2026101511101072000_jnumed.126.272939v1.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2584"},{"key":"2026101511101072000_jnumed.126.272939v1.15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2428"},{"key":"2026101511101072000_jnumed.126.272939v1.16","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2147\/OTT.S63424","article-title":"B7-H3 expression in breast cancer and upregulation of VEGF through gene silence","volume":"7","author":"Sun","year":"2014","journal-title":"Onco Targets Ther."},{"key":"2026101511101072000_jnumed.126.272939v1.17","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1158\/0008-5472.CAN-23-4099","article-title":"A dual-payload antibody\u2013drug conjugate targeting CD276\/B7-H3 elicits cytotoxicity and immune activation in triple-negative breast cancer","volume":"84","author":"Zhou","year":"2024","journal-title":"Cancer Res."},{"key":"2026101511101072000_jnumed.126.272939v1.18","doi-asserted-by":"crossref","first-page":"e002455","DOI":"10.1136\/jitc-2021-002455","article-title":"B7 score and T cell infiltration stratify immune status in prostate cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"J Immunother Cancer."},{"key":"2026101511101072000_jnumed.126.272939v1.19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073976"},{"key":"2026101511101072000_jnumed.126.272939v1.20","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/neuonc\/noaf039","article-title":"Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-omburtamab for diffuse intrinsic pontine glioma","volume":"27","author":"Souweidane","year":"2025","journal-title":"Neuro Oncol."},{"key":"2026101511101072000_jnumed.126.272939v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.01.002"},{"key":"2026101511101072000_jnumed.126.272939v1.22","doi-asserted-by":"crossref","first-page":"e186388","DOI":"10.1172\/JCI186388","article-title":"A whole-body imaging technique for tumor-specific diagnostics and screening of B7H3-targeted therapies","volume":"135","author":"Xia","year":"2025","journal-title":"J Clin Invest."},{"key":"2026101511101072000_jnumed.126.272939v1.23","doi-asserted-by":"publisher","DOI":"10.1021\/acscombsci.8b00156"},{"key":"2026101511101072000_jnumed.126.272939v1.24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41523-023-00578-3","article-title":"Emerging systemic therapy options beyond CDK4\/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer","volume":"9","author":"Ma","year":"2023","journal-title":"NPJ Breast Cancer."},{"key":"2026101511101072000_jnumed.126.272939v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01245-X"},{"key":"2026101511101072000_jnumed.126.272939v1.26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01805-y"},{"key":"2026101511101072000_jnumed.126.272939v1.27","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s40265-020-01411-y","article-title":"Targeting HER2 in breast cancer: latest developments on treatment sequencing and the introduction of biosimilars","volume":"80","author":"Tesch","year":"2020","journal-title":"Drugs."},{"key":"2026101511101072000_jnumed.126.272939v1.28","first-page":"22","article-title":"Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer","volume":"7","author":"Saleh","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"2026101511101072000_jnumed.126.272939v1.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549"},{"key":"2026101511101072000_jnumed.126.272939v1.30","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26576"},{"key":"2026101511101072000_jnumed.126.272939v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22618-x"},{"key":"2026101511101072000_jnumed.126.272939v1.32","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.18632\/oncotarget.6902","article-title":"Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT\/mTOR inhibitors","volume":"7","author":"Nunes-Xavier","year":"2016","journal-title":"Oncotarget."},{"key":"2026101511101072000_jnumed.126.272939v1.33","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013210"},{"key":"2026101511101072000_jnumed.126.272939v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113854"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:10:17Z","timestamp":1792087817000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":34,"alternative-id":["10.2967\/jnumed.126.272939"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272939","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}